Multiple Myeloma

Inside Celgene’s Revlimid: Strong Patient Demand in 4Q16
Market Realist
Tue, 01/31/17 - 09:52 am
Celgene
Revlimid
Multiple Myeloma
Is This Johnson & Johnson's Next Billion-Dollar Blockbuster?
Motley Fool
Thu, 01/26/17 - 10:18 am
JNJ
Darzalex
Multiple Myeloma
Is Donald Trump Celgene's Biggest Risk in 2017?
Motley Fool
Tue, 01/17/17 - 10:23 pm
Celgene
Revlimid
drug pricing
Multiple Myeloma
Donald Trump
3 Biggest Risks for Celgene Corporation
Motley Fool
Thu, 12/15/16 - 06:44 pm
Celgene
Darzalex
Multiple Myeloma
Allergan
generics
Abraxane
Revlimid
Bluebird bio stock gains on impressive early cancer trial results
Bizjournals.com
Thu, 12/1/16 - 09:53 am
Bluebird Bio
clinical trials
bb2121
Multiple Myeloma
You'll Never Guess Who Owns the Most Spectacular New Cancer Drug
Motley Fool
Mon, 11/21/16 - 02:25 pm
JNJ
Darzalex
Multiple Myeloma
Powerful Dems orchestrated campaign at FDA to provide Biogen drug to a dying, high-profile fundraiser
Endpoints
Sun, 10/16/16 - 12:32 pm
FDA
Biogen
Multiple Myeloma
compassionate use guidelines
Celgene CEO: myeloma and glioblastoma both priorities
BioPharma Dive
Tue, 10/4/16 - 03:56 pm
Celgene
Multiple Myeloma
glioblastoma
marizomib
R&D
Amgen’s Backup Plan for Kyprolis (AMGN)
Investopedia
Sun, 10/2/16 - 10:22 am
Amgen
Kyprolis
Multiple Myeloma
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thu, 09/29/16 - 08:13 am
Amgen
Kyprolis
clinical trials
Multiple Myeloma
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Amgen
Multiple Myeloma
Kyprolis
clinical trials
Takeda
Velcade
Karyopharm sets a course for the FDA with positive PhIIb multiple myeloma data
Endpoints
Tue, 09/6/16 - 10:56 am
Karyopharm
FDA
clinical trials
Multiple Myeloma
Selinexor
3 Clinical-Stage Biotech Stocks With News About To Break
Motley Fool
Thu, 09/1/16 - 09:30 am
Novavax
RSV F vaccine
Agile Therapeutics
birth control patch
Twirla
Karyopharm
Selinexor
Multiple Myeloma
Juno Throws Down The Multiple Myeloma Gauntlet To Bluebird
Seeking Alpha
Tue, 08/9/16 - 10:54 pm
Juno Therapeutics
Multiple Myeloma
Bluebird Bio
CAR-T
Juno strikes deal to join bluebird, Novartis in busy multiple myeloma niche
Fierce Biotech
Sat, 08/6/16 - 01:19 pm
Juno Therapeutics
Bluebird Bio
Novartis
Multiple Myeloma
BCMA
Inside AbbVie’s Plans to Target Multiple Myeloma and Acute Myeloid Leukemia Segments with Venclexta
Market Realist
Mon, 07/11/16 - 10:50 am
AbbVie
Multiple Myeloma
acute myeloid leukemia
Venclexta
Johnson & Johnson Courting Huge Revenue Potential In Multiple Myeloma Space
Seeking Alpha
Tue, 06/7/16 - 11:12 am
JNJ
Multiple Myeloma
daratumumab
ASCO 2016
J&J myeloma drug, in combo regimen, delays worsening of the disease
Yahoo/Reuters
Sun, 06/5/16 - 12:01 pm
JNJ
Multiple Myeloma
Darzalex
Takeda
Velcade
ASCO 2016
Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment
Yahoo/Benzinga
Fri, 05/27/16 - 10:43 pm
Amgen
CHMP
Kyprolis
Multiple Myeloma
Janssen's multiple myeloma drug passes muster in Europe
BioPharma Dive
Tue, 05/24/16 - 11:42 pm
Janssen
Multiple Myeloma
Europe
JNJ
Darazalex

Pages